Skip to content

Harrow HROW Net Operating Loss Carryforwards

Net Operating Loss Carryforwards at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$176.1M+27.1%
Warby Parker logo
Warby ParkerWRBY
$299.9M-1.8%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:OperatingLossCarryforwards.

The official record: Harrow’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's net operating loss carryforwards.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's net operating loss carryforwards?
Harrow (HROW) reported net operating loss carryforwards of $37.12M in Q4 2025.
How has Harrow's net operating loss carryforwards changed year-over-year?
Harrow's net operating loss carryforwards increased by 34.2% year-over-year, from $27.67M to $37.12M.
What is the long-term trend for Harrow's net operating loss carryforwards?
Over 5 years (2020 to 2025), Harrow's net operating loss carryforwards has grown at a -9.4% compound annual growth rate (CAGR), from $60.91M to $37.12M.
What does net operating loss carryforwards mean?
These are tax assets representing losses that can be used to reduce taxable income in future periods. They provide a potential future tax shield, improving cash flow by lowering future tax payments. Investors monitor these to estimate the duration and magnitude of potential tax savings.